ACDM News Item

Recent News in Regulatory Landscape

Date: June 11, 2026

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece detailing recent news across the regulatory landscape in Clinical Data Management.

Read their update here:

Exciting news in the regulatory space! ICH released ICH E6 R3 Annex 2 on June 3, 2026. According to the introduction Annex 2 supplements R3 and Annex 1 approach to applying risk proportionate approaches to trial design and conduct. Annex 2 expands on this with a focus on decentralized trials approaches, pragmatic elements and real-world data (RWD).

The ACDM DMEG on Regulatory Considerations is looking forward to reviewing Annex 2 and publishing a summary of the highlights that impact data management. But in the interim we wanted to share the document with you. You can access the document using the link below.

https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Annex%202_Guideline_Step%204_2026_0603_0.pdf

The Regulatory Considerations Expert Group provides guidance on a range of topics related to regulatory frameworks in clinical data management. This includes where to find applicable regulations, how to stay informed about new and emerging requirements, and which specific areas are relevant to data management, along with what they mean in practice. Find out more about their work here: https://acdmglobal.org/regulatory-considerations-dmeg/

Explore More News

Welcome Boehringer Ingelheim as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Boehringer . . .

Welcome Datacapt as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Datacapt as a . . .

Welcome Climedo as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Climedo as a . . .

Clinical Trials for Medicines – New Notification Scheme

The MHRA have recently launched a new notification scheme, the first step in their . . .

EMA Management Board: Highlights of October 2023 meeting

The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the . . .

Welcome Mednet as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Mednet as a new . . .

Welcome Allucent as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .

Welcome KCR as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .

Welcome Debiopharm as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025

The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3

As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines

The EMA has opened a public consultation on a reflection paper presenting views . . .